Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trial. - McIlroy, Graham; Gaskell, Charlotte; Jackson, Aimee; Yafai, Emily; Tasker, Rachel; Thomas, Catherine; Fox, Sonia; Boucher, Rebecca; Ghebretinsea, Fitsum; Harrison, Claire; Mead, Adam J.; McMullin, Mary Frances (BMC Cancer, 2025)